...
首页> 外文期刊>Frontiers in Molecular Biosciences >Development of a Machine Learning-Based Autophagy-Related lncRNA Signature to Improve Prognosis Prediction in Osteosarcoma Patients
【24h】

Development of a Machine Learning-Based Autophagy-Related lncRNA Signature to Improve Prognosis Prediction in Osteosarcoma Patients

机译:发展基于机器学习的自噬相关的LNCrNA签名,以改善骨肉瘤患者的预后预测

获取原文
           

摘要

Background: Osteosarcoma is a frequent bone malignancy in children and young adults. Despite the availability of some prognostic biomarkers, most of them fail to accurately predict prognosis in osteosarcoma patients. In this study, we used bioinformatics tools and machine learning algorithms to establish an autophagy-related long non-coding RNA (lncRNA) signature to predict the prognosis of osteosarcoma patients. Methods: We obtained expression and clinical data from osteosarcoma patients in the Therapeutically Applicable Research to Generate Effective Treatments (TARGET) and Gene Expression Omnibus (GEO) databases. We acquired an autophagy gene list from the Human Autophagy Database (HADb) and identified autophagy-related lncRNAs by co-expression analyses. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analyses of the autophagy-related lncRNAs were conducted. Univariate and multivariate Cox regression analyses were performed to assess the prognostic value of the autophagy-related lncRNA signature and validate the relationship between the signature and osteosarcoma patient survival in an independent cohort. We also investigated the relationship between the signature and immune cell infiltration. Results: We initially identified 69 autophagy-related lncRNAs, 13 of which were significant predictors of overall survival in osteosarcoma patients. Kaplan-Meier analyses revealed that the 13 autophagy-related lncRNAs could stratify patients based on their outcomes. Receiver operating characteristic curve analyses confirmed the superior prognostic value of the lncRNA signature compared to clinically used prognostic biomarkers. Importantly, the autophagy-related lncRNA signature predicted patient prognosis independently of clinicopathological characteristics. Furthermore, we found that the expression levels of the autophagy-related lncRNA signature were significantly associated with the infiltration levels of different immune cell subsets, including T cells, NK cells, and dendritic cells. Conclusion: The autophagy-related lncRNA signature established here is an independent and robust predictor of osteosarcoma patient survival. Our findings also suggest that the expression of these 13 autophagy-related lncRNAs may promote osteosarcoma progression by regulating immune cell infiltration in the tumor microenvironment.
机译:背景:骨肉瘤是儿童和年轻成年人的常见骨骼恶性肿瘤。尽管有一些预后的生物标志物,但大多数未能准确预测骨肉瘤患者的预后。在这项研究中,我们使用生物信息工具和机器学习算法来建立与自噬相关的长非编码RNA(LNCRNA)签名,以预测骨肉瘤患者的预后。方法:我们从骨肉瘤患者中获得表达和临床资料,治疗适用的研究,以产生有效的治疗(靶)和基因表达综合征(GEO)数据库。我们从人类自噬数据库(HADB)中获得了自噬基因列表,并通过共表达分析确定了与自噬相关的LNCRNA。进行基因本体(GO)和京都基因组(KEGG)富集的自噬相关的LNCRNA的途径分析。进行单变量和多元COX回归分析,以评估自噬相关的LNCRNA签名的预后值,并验证独立队列中签名和骨肉瘤患者生存之间的关系。我们还研究了签名和免疫细胞浸润之间的关系。结果:我们初始鉴定了69名与自噬相关的LNCRNA,其中13名是骨肉瘤患者整体存活的显着预测因子。 Kaplan-Meier分析显示,13型自噬相关的LNCRNA可以根据其结果分层患者。接收器操作特征曲线分析证实了与临床使用的预后生物标志物相比的LNCRNA签名的优异预后值。重要的是,与临床病理特征无关的自噬相关的LNCRNA签名预测患者预后。此外,我们发现自噬相关的LNCRNA签名的表达水平与不同免疫细胞亚群的渗透水平显着相关,包括T细胞,NK细胞和树突细胞。结论:在此建立的自噬相关的LNCRNA签名是骨肉瘤患者存活的独立且坚固的预测因子。我们的研究结果还表明,通过调节肿瘤微环境中的免疫细胞浸润来促进这13个自噬相关的LNCRNA的表达可以促进骨肉瘤进展。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号